HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of thyrotropin-releasing hormone on the neurologic impairment in rats with spinal cord injury: treatment starting 24 h and 7 days after injury.

Abstract
The effect of treatment with thyrotropin-releasing hormone (TRH) or naloxone on the neurologic impairment after spinal cord injury was studied in rats with the severest neurologic impairment (complete paraplegia, no withdrawal response upon tail pinching, and urinary incontinence) 24 h and 7 days after injury. Subcutaneous treatment with TRH (2.5, 10 and 40 mg/kg per day) once daily for 7 consecutive days starting 24 h or 7 days after injury improved the neurologic function in the rats with cord injury in a dose-related manner, with a minimum effective dose of less than 2.5 mg/kg per day in both cases. However, subcutaneous treatment with naloxone (40 mg/kg per day) once daily for 7 consecutive days starting 24 h after injury did not exert any beneficial effects on neurologic function. These results indicate that TRH but not naloxone treatment starting 24 h and as late as 7 days after injury is effective in rats with the severest neurologic impairment following spinal cord injury. Thus, it is suggested that the duration of the effectiveness of late treatment with TRH on the neurologic impairment in rats with spinal cord injury is more than 1 week, while the duration with naloxone is less than 24 h.
AuthorsT Hashimoto, N Fukuda
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 203 Issue 1 Pg. 25-32 (Oct 02 1991) ISSN: 0014-2999 [Print] Netherlands
PMID1797554 (Publication Type: Journal Article)
Chemical References
  • Naloxone
  • Thyrotropin-Releasing Hormone
Topics
  • Animals
  • Dose-Response Relationship, Drug
  • Male
  • Naloxone (therapeutic use)
  • Nervous System (physiopathology)
  • Paraplegia (drug therapy)
  • Rats
  • Rats, Inbred Strains
  • Spinal Cord Injuries (complications, drug therapy, physiopathology)
  • Thyrotropin-Releasing Hormone (therapeutic use)
  • Time Factors
  • Urinary Incontinence (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: